Your browser doesn't support javascript.
loading
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
El Missiry, Mohamed; Adnan Awad, Shady; Rajala, Hanna L; Al-Samadi, Ahmed; Ekblom, Marja; Markevän, Berit; Åstrand-Grundström, Ingbritt; Wold, Maren; Svedahl, Ellen Rabben; Juhl, Birgitte Ravn; Bjerrum, Ole Weis; Haulin, Inger; Porkka, Kimmo; Olsson-Strömberg, Ulla; Hjorth-Hansen, Henrik; Mustjoki, Satu.
Afiliação
  • El Missiry M; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Haartmaninkatu 8, P.O. Box 700, 00290, Helsinki, Finland.
  • Adnan Awad S; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Haartmaninkatu 8, P.O. Box 700, 00290, Helsinki, Finland.
  • Rajala HL; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Haartmaninkatu 8, P.O. Box 700, 00290, Helsinki, Finland.
  • Al-Samadi A; Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland.
  • Ekblom M; Skåne University Hospital, Lund, Sweden.
  • Markevän B; Department of Hematology, Umeå University Hospital, Umeå, Sweden.
  • Åstrand-Grundström I; Skåne University Hospital, Lund, Sweden.
  • Wold M; Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Svedahl ER; Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Juhl BR; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bjerrum OW; Department of Hematology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Haulin I; Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.
  • Porkka K; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Haartmaninkatu 8, P.O. Box 700, 00290, Helsinki, Finland.
  • Olsson-Strömberg U; Department of Hematology, Uppsala University Hospital, Uppsala, Sweden.
  • Hjorth-Hansen H; Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
  • Mustjoki S; Department of Hematology, St Olavs Hospital, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
J Cancer Res Clin Oncol ; 142(5): 1041-50, 2016 May.
Article em En | MEDLINE | ID: mdl-26746653
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Proteínas Tirosina Quinases / Linfócitos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Sistema Imunitário Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Proteínas Tirosina Quinases / Linfócitos / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Sistema Imunitário Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Finlândia